|
New Techniques to Increase Drug Candidate Survivability | ||||
Strategic Research Institute
, The Park Hyatt at the Bellevue Hotel - Philadelphia, PA September 11-12, 2000 |
||||
DIVIDED INTO 4 SECTIONS - Critical Technologies & Scientific Arena - In Vitro/ In Vivo Correlations - Early ADME/Predictive Toxicology - Genetics/Genomics/Proteomics |
||||
Organized by: |
Strategic Research Institute |
|||
Invited Speakers: |
GLAXO WELLCOME AVENTIS ELI LILLY & CO PARKE-DAVIS QUINTILES TREGA BIOSCIENCES PFIZER, INC. IN VITRO TECHNOLOGIES, INC. ASTRAZENECA PHARMACIA CORP CEREP, INC. ENTELOS, INC. LYNX THERAPEUTICS, INC. CYPROTEX CURAGEN CORPORATION ARQULE, INC. DUPONT PHARMACEUTICALS MERCK & CO. |
|||
Deadline for Abstracts: |
Friday - June 23, 2000 |
|||
Registration: |
Tel: 212-967-0095, ext. 245 or 800-599-4950, ext. 245 |
|||
Email for Requests and Registration: | gpascual@srinstitute.com | |||
Posted by: Glenn Pascual Host: 12.3.58.109 date: June 19, 2000 19:24:27 Generated by meetings and positions 2.0 by Kai Garlipp Logo and Logo Images by Art for BioMed / Syrinx GmbH - Frankfurt / Germany. 4.1 (c) 1995-99 HUM-MOLGEN. All rights reserved. Liability and Copyright. |